ATH 33.3% 0.4¢ alterity therapeutics limited

Ann: Appendix 4E Preliminary Final Report, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,106 Posts.
    lightbulb Created with Sketch. 103
    Hi rebekah,

    Apologies, i should have wrote my post abit clearer, although i was rushing to get ready for an event.

    So please allow me to take 2.

    Yes not surprised, but it also read very doom and gloom, but going off recent results from the 202 study and the last line which I highlighted, it appears the directors are soundly confident in a good result and further progression, hence hopefully results are coming in thick and fast for a excellent end of phase 2 study read out. But we will not be spared a CR.

    Anyways, let science do its thing, and look forward to a exceptional readout read out, with institutional and MJFF stepping in with strong backing.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.